Form D — Aegle Therapeutics Corp
0001231919-26-000232 · filed Mar 3, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $700,000
- Reported amount sold
- $455,695
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aegle Therapeutics Corp
- CIK
- 1797825
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 400 TRADECENTER
WOBURN, Massachusetts 01801 - Phone
- 781-918-8449
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shelley Hartman · Executive OfficerWoburn, Massachusetts Find on LinkedIn ↗
-
David Schimel · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Leon Moulder · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Scott Braunstein · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Steve O'Hara · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Evangelos Badiavas · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Mikio Tanji · DirectorWoburn, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗